Hi, How Can We Help?
Advertisement
5

Do children with ADHD and certain genes show reduced cortical thickness? 

Posted:    Author:  

Victoria Rowe, MSc

   Reviewed by:  

Dr. Rebecca Fernandez, MBBS

Yes, research has shown that children with ADHD and specific ADHD genes often exhibit reduced cortical thickness in certain areas of the brain. The cortex is the outer layer of the brain, involved in higher functions such as attention, decision-making, and impulse control, all of which are often impaired in ADHD. Advances in brain imaging have allowed scientists to measure cortical thickness, revealing structural differences that may contribute to ADHD symptoms. 

How ADHD genes influence cortical thickness 

Cortical thickness is influenced by genetic and environmental factors during brain development. Studies using advanced brain imaging techniques have shown that paediatric ADHD is often associated with thinning in brain regions critical for attention and executive function. This thinning is particularly noticeable in areas such as the prefrontal cortex, which plays a central role in managing focus and controlling impulses. 

Certain ADHD risk genes have been linked to these structural changes. For instance, dopamine-related genes like DAT1 (dopamine transporter) and DRD4 (dopamine receptor) have been associated with reduced cortical thickness, particularly in regions like the prefrontal cortex and striatum areas that are involved in regulating attention, behaviour, and reward processing. 

The link between neurodevelopment and cortical thickness 

The link between neurodevelopment and cortical thickness highlights how delayed brain maturation in ADHD affects attention, impulse control, and cognitive processing. 

Neurodevelopmental factors  

ADHD is a neurodevelopmental disorder, and changes in cortical thickness can reflect delays or disruptions in brain maturation. Children with ADHD may experience slower cortical growth, leading to thinner cortical regions compared to their neurotypical peers. Genetic factors, such as those affecting dopamine regulation, can influence these developmental trajectories, leading to structural brain differences. 

Brain imaging and ADHD diagnosis  

While reduced cortical thickness is not exclusive to ADHD, brain imaging studies have consistently found these differences in children with the disorder. These findings help researchers understand the biological basis of ADHD and may eventually be used to complement traditional diagnostic methods based on behavioural symptoms. 

Why this matters for ADHD treatment 

This matters for ADHD treatment because understanding cortical development patterns can guide early intervention and more targeted therapeutic approaches. 

Biomarkers for diagnosis  

Understanding the relationship between ADHD cortical thickness and specific genetic variants could lead to more objective diagnostic tools. Brain imaging combined with genetic information may one day help clinicians identify ADHD earlier, particularly in cases where behavioural symptoms are subtle. 

Personalised interventions  

Knowing how certain genes influence cortical thickness can also guide more personalised treatment strategies. For example, therapies targeting cognitive control or brain plasticity could help children with ADHD strengthen specific brain regions that may be underdeveloped or thinner. 

Better understanding of neurodevelopment 

These insights into the neurodevelopmental basis of ADHD can lead to improved interventions that support optimal brain development in children with ADHD, especially during key developmental periods. 

ADHD cortical thickness genetics provides critical insights into the biological underpinnings of ADHD. By linking genetic variants to brain structure differences, researchers are uncovering new pathways for personalised ADHD care and treatment. 

Visit providers like ADHD Certify for personal consultations that incorporate genetic and brain imaging insights in ADHD management.

 For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic studies and biomarkers.

Advertisement
6
Victoria Rowe, MSc
Written By Victoria Rowe, MSc

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewed By Dr. Rebecca Fernandez, MBBS

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Advertisement
2
Autism desk